HRT Financial’s Enfusion, Inc. ENFN Stock Holding History

HRT Financial’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-256,987	Closed	-$2.87M	–	3784
2025 Q1	$2.87M	Buy	256,987 +191,726	+294%	+$2.12M	0.02%	661
2024 Q4	$672K	Buy	+65,261	New	+$631K	﹤0.01%	1296
2024 Q2	–	Sell	-23,459	Closed	-$216K	–	3296
2024 Q1	$216K	Buy	+23,459	New	+$206K	﹤0.01%	1732
2022 Q3	–	Sell	-61,071	Closed	-$623K	–	3640
2022 Q2	$623K	Buy	+61,071	New	+$675K	0.01%	1330

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HRT Financial's ENFN Position: Q2 2025 in Review

HRT Financial sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 256,987 shares — an estimated $2.87M sold.

HRT Financial first reported a position in ENFN in Q2 2022 and held it in 4 quarters. The position peaked at $2.87M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

HRT Financial reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 256,987 Enfusion, Inc. shares in Q2 2025, an estimated $2.87M.
HRT Financial first reported a position in Enfusion, Inc. in Q2 2022 and held it in 4 quarters.
HRT Financial's Enfusion, Inc. position peaked at $2.87M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.